Target intelligence / Profile preview

VMA21 vacuolar H+-ATPase homolog pseudogene (null)

Target
null
Molecular classification
Pseudogene
01

Overview

ENSG00000282413 encodes a **pseudogene** of the VMA21 vacuolar H+-ATPase homolog. Unlike the protein-coding VMA21 gene (which is required for assembly of the V0 complex of vacuolar ATPase and whose deficiency leads to X-linked myopathy with excessive autophagy), this pseudogene is **non-protein coding** and does not perform known biological functions or act as a therapeutic target[4]. It should be distinguished from the protein-coding VMA21 gene, which is the relevant molecular target in disease biology[2][3][4]. Additional context and clarification: ENSG00000282413 is annotated in Ensembl as a pseudogene, and does not produce a functional protein[4]. The canonical therapeutic target relevant in literature is the protein-coding **VMA21 (Vacuolar ATPase Assembly Factor VMA21)**, not this pseudogene[2][3][7]. If the intended query is the active protein-coding VMA21 gene, refer instead to “VMA21 vacuolar ATPase assembly factor”[2][7]. There are no reported drugs, biomarkers, or therapeutic mechanisms associated with this pseudogene. Summary of guidance: This pseudogene (ENSG00000282413) is **not a therapeutic target**, has **no reported biological or drug-related function**, and should **not be used in lieu of the protein-coding VMA21 gene** for molecular or therapeutic studies[4].

Other names
VMA21 pseudogeneVMA21 vacuolar H+-ATPase homolog (S. cerevisiae) pseudogene[4]

Beyond the preview

Go deeper on VMA21 vacuolar H+-ATPase homolog pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VMA21 vacuolar H+-ATPase homolog pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call